Acute Myocardial Infarction (AMI) Clinical Trial
Official title:
University of Wisconsin hMSC Cell Bank: Bone Marrow Donor Protocol
The objective of this protocol is to use established standard criteria and methods for the collection of hMSC (human mesenchymal stromal cells) from healthy bone marrow donors. The hMSC collected from the donors will use to develop well-defined and reproducible cell banks. Standard manufacturing procedures and quality control testing methods will be used to characterize and evaluate the final cell product. After the cell banks are created, these cell products will be used in future translational or clinical research.
Cell banks will be manufactured and cellular products used for future translational or clinical research. ;
Intervention Model: Single Group Assignment, Masking: Open Label
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02290080 -
Determination of the Role of Oxygen in Suspected Acute Myocardial Infarction by Biomarkers
|
Phase 3 | |
Completed |
NCT00211172 -
HMO Research Network CERT: Acute Myocardial Infarction
|
N/A | |
Completed |
NCT03725826 -
Risk Stratification After Acute Myocardial Infarction With Cardiac MRI
|
||
Not yet recruiting |
NCT06118281 -
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
|
Phase 3 | |
Completed |
NCT02804906 -
Rehabilitation in the Home Setting for Older Adults In the Early Period After Myocardial Infarction
|
N/A | |
Completed |
NCT01890018 -
Partners and Alerts: A Study of Social Forces in Medication Adherence
|
N/A | |
Completed |
NCT05696379 -
Angiography Derived Index of Microcirculatory Resistance in Patients With Acute Myocardial Infarction
|
||
Recruiting |
NCT02018497 -
Essential Hypotension and Allostasis Registry
|
||
Completed |
NCT00833612 -
Counterpulsation Reduces Infarct Size Pre-PCI for AMI
|
Phase 4 | |
Completed |
NCT00781118 -
AngelMed for Early Recognition and Treatment of STEMI
|
Phase 3 | |
Not yet recruiting |
NCT04835207 -
Metabolic Profile as a Predictor of No-reflow in Diabetic Patients
|